Compass Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
CMPX
CUSIP
20454B104
Type
Equity
Class
COM
Num filings
222
Total reported value, excl. options
$431 M
Manager Report Date Value ($000) Shares Option Type